Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $112.80 | $24.66 | 357.46% | 212.83x | 193.35x | 14.31x | 17.28x | 1.65x | $106.92M | 0.90% | $705.78M | 6.70 | $12.09B | 1,541.35 | ||
| LQDA | LIQUIDIA CORP | $83.85 | $17.14 | 389.14% | 349.38x | 25.23x | 25.62x | 68.67x | 1.69x | $41.15M | 0.56% | $108.58M | 1.23 | $7.42B | 138.42 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.13 | $2.70 | 201.30% | 116.14x | 72.46x | 4.40x | 107.88x | 1.11x | $47.52M | 3.43% | $13.01M | 0.08 | $1.55B | 29.02 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $220.33 | $95.06 | 131.77% | 36.12x | 30.41x | 6.13x | 21.77x | 1.10x | $793.95M | 2.70% | $1.35B | 10.14 | $30.76B | 26.08 | ||
| HALO | HALOZYME THERAPEUTICS INC | $82.27 | $68.06 | 20.88% | 27.79x | 9.91x | 6.44x | 44.43x | 0.50x | $667.65M | 6.87% | $219.64M | 1.86 | $11.59B | 18.58 | ||
| ADMA | ADMA BIOLOGICS INC | $8.74 | $8.80 | -0.67% | 12.67x | 10.42x | 4.05x | 5.19x | 0.53x | $107.90M | 5.23% | $390.33M | 1.65 | $2.09B | 9.41 | ||
| ASND | ASCENDIS PHARMA A | $243.45 | $76.61 | 217.78% | 25.80x | 16.74x | 14.85x | 26.34x | 2.69x | $52.94M | 0.35% | $574.09M | 9.24 | $15.50B | 166.23 | ||
| KRYS | KRYSTAL BIOTECH INC | $312.57 | $86.77 | 260.21% | 37.80x | 40.99x | 20.95x | 6.81x | 2.23x | $257.78M | 2.79% | $1.36B | 46.03 | $8.83B | 37.86 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $73.41 | $16.50 | 344.84% | 68.61x | 58.31x | 6.77x | 8.76x | 2.12x | $182.84M | 3.21% | $654.15M | 8.43 | $5.56B | 46.36 | ||
| RPRX | ROYALTY PHARMA PLC | $57.17 | $38.84 | 47.21% | 29.93x | 10.65x | 10.23x | 3.31x | 0.63x | $2.34B | 9.37% | $9.94B | 22.75 | $41.29B | 35.49 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.00 | $37.52 | 59.88% | 42.85x | 16.15x | 3.56x | 1.87x | 0.63x | $767.06M | 6.64% | $6.21B | 32.27 | $9.95B | 20.63 | ||
| VCEL | VERICEL CORP | $46.05 | $8.93 | 415.53% | 95.94x | 95.52x | 7.68x | 6.37x | 2.27x | $61.66M | 2.62% | $370.04M | 7.25 | $2.33B | 52.79 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.60 | $33.63 | 5.86% | 14.07x | 9.38x | 2.29x | 2.26x | 0.55x | $341.79M | 16.60% | $910.35M | 15.75 | $1.63B | 6.88 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $251.58 | $47.12 | 433.91% | 535.28x | 9.75x | 3.51x | 3.48x | 1.81x | $1.30B | 8.33% | $4.53B | 73.22 | $19.34B | 28.65 | ||
| TGTX | TG THERAPEUTICS INC | $46.17 | $23.40 | 97.27% | 14.34x | 32.77x | 9.52x | 12.12x | 2.07x | -$14.19M | -0.21% | $583.13M | 4.04 | $7.38B | 49.17 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $292.04 | $97.85 | 198.44% | 36.97x | 31.60x | 21.15x | 5.87x | 1.62x | $122.22M | 2.10% | $997.32M | 50.16 | $6.19B | 27.44 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.15 | $8.59 | -86.61% | 4.26x | -3.89x | 1.08x | 1.26x | 0.05x | $7.24M | 10.96% | $52.93M | 0.92 | $12.93M | 0.83 | ||
| TECH | BIO-TECHNE CORP | $72.14 | $16.02 | 350.43% | 101.61x | 34.57x | 9.31x | 5.42x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.38B | 44.44 | ||
| MDXG | MIMEDX GROUP INC | $4.27 | $1.11 | 283.98% | 106.75x | -38.06x | 1.78x | 2.88x | 1.51x | $44.50M | 7.05% | $216.00M | 1.46 | $503.76M | 22.09 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.53 | $1.96 | 79.80% | 14.71x | 15.27x | 2.16x | 3.41x | 1.50x | $4.11M | 1.44% | $82.33M | 1.03 | $217.17M | 10.22 | ||
| UTHR | UNITED THERAPEUTICS CORP | $516.31 | $228.25 | 126.21% | 17.63x | 18.86x | 7.09x | 3.71x | 2.05x | $1.02B | 4.53% | $5.90B | 135.66 | $20.64B | 12.04 | ||
| EXEL | EXELIXIS INC | $55.06 | $29.06 | 89.49% | 17.65x | 17.11x | 5.99x | 7.15x | 1.33x | $917.69M | 6.45% | $1.94B | 7.49 | $13.78B | 13.05 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $470.72 | $158.66 | 196.69% | 27.67x | 24.34x | 9.79x | 6.17x | 2.07x | $3.71B | 3.10% | $19.36B | 76.20 | $115.96B | 21.50 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $759.24 | $416.55 | 82.27% | 18.10x | 16.26x | 5.02x | 2.46x | 1.19x | $3.76B | 4.82% | $31.71B | 308.48 | $78.42B | 13.64 | ||
| INCY | INCYTE CORP | $118.43 | $60.41 | 96.03% | 14.58x | 15.58x | 4.08x | 3.78x | 1.95x | $1.92B | 8.09% | $6.34B | 31.66 | $20.05B | 9.70 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.